Colinz Laboratories Limited has scheduled a meeting of the Board of Directors on Thursday, July 3, 2026 at 3:30 p.m. at the company's registered office located at 4-101, Pratik Industrial Estate, Mulund Link Road, Mumbai, Maharashtra, 400078.

The board meeting agenda includes the following items:

  • Consideration, approval, and taking on record of Un-Audited Financial Results for the Quarter Ended June 2026 (Q1 FY2027)
  • Approval of Director's Report for the year ended March 31, 2026
  • Approval of Management Discussion, Corporate Governance Report, CEO's Certification, and other required documents
  • Taking note of the Secretarial Audit Report issued by M/s. Sanjay Dholakia & Associates, Practicing Company Secretaries for the financial year ended March 31, 2026
  • Fixing dates of Book Closure and Record Date
  • Recommendation for approval of appointment of Secretarial Auditor for the Financial Year 2026-27
  • Recommendation for approval of appointment of Internal Auditor CA. Ajay Ramsevan Sharma for the Financial Year 2026-27
  • Approval of draft notice of forthcoming Annual General Meeting
  • Any other specific point with the permission of the chair

The company had previously intimated the exchange on June 30, 2026 about the closure of the trading window for designated persons and their immediate relatives. This trading window closure period shall end on the second trading day after the board meeting date, which is July 30, 2026, following the declaration of financial results for the First Quarter ended June 30, 2026.

The intimation is made pursuant to Regulation 29(2) and Regulation 33 of SEBI (LODR) Regulations, 2015. A copy of this intimation is available on the company's website at www.findoc-c11.in.

Company CIN: L24200MH1986PLC041128